Your browser doesn't support javascript.
Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients.
Dimeglio, Chloé; Del Bello, Arnaud; Chapuy-Regaud, Sabine; Esposito, Laure; Danet, Chloé; Couat, Chloé; Izopet, Jacques; Kamar, Nassim.
  • Dimeglio C; Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France.
  • Del Bello A; INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
  • Chapuy-Regaud S; Paul Sabatier University, Toulouse, France.
  • Esposito L; INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
  • Danet C; Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France.
  • Couat C; Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France.
  • Izopet J; INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
  • Kamar N; Paul Sabatier University, Toulouse, France.
Transplantation ; 106(5): e275-e276, 2022 05 01.
Article in English | MEDLINE | ID: covidwho-1741066
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Limits: Humans Language: English Journal: Transplantation Year: 2022 Document Type: Article Affiliation country: TP.0000000000004087

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Limits: Humans Language: English Journal: Transplantation Year: 2022 Document Type: Article Affiliation country: TP.0000000000004087